Reply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9. [electronic resource]
Producer: 20190321Description: e59-e60 p. digitalISSN:- 1873-7560
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.